Hopkinson Craig C.'s Form 4 filing
Alkermes plc. (ALKS) · filed Dec 5, 2025
- Accession no.
- 0001520262-25-000014
- Filed
- Dec 5, 2025
- Trade date
- Dec 3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $112.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hopkinson Craig C.CIK 0001730048 | Officer (EVP R&D, Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Ordinary Shares | MOption exerciseAcquired | +3,748 | $19.34 | +$72,486.32 | 69,488 | Direct | |
| Dec 3, 2025 | Ordinary Shares | SSaleDisposed | −3,748 | $30.00F3 | −$112,440 | 65,740 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Ordinary Shares | MOption exerciseDisposed | −3,748 | $0.00 | $0 | 36,356 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.